Mobile

Efficacy and safety of riociguat in patients with high blood pressure in the blood vessels of the lungs associated with interstitial pneumonias of unknown cause

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-024332-42

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the efficacy and safety of 26-weeks of treatment with riociguat vs. placebo in patients with symptomatic PH associated with IIP

Critère d'inclusion

  • pulmonary hypertension associated with idiopathic interstitial pneumonias

Liens